Clinical outcomes of bilateral implantation of a new non-diffractive extended-vision intraocular lens (AcrySof ® IQ vivity)

医学 多焦点人工晶状体 双眼视觉 人工晶状体 超声乳化术 眼科 视力 屈光度 散光 验光服务 折射误差 镜头(地质) 患者满意度 视觉障碍 白内障手术 近视力 眼优势
作者
Celso Costa,Telmo Cortinhal,Inês Figueiredo,María Silva,Miguel Raimundo,Maria J. Quadrado,Joaquim Murta
出处
期刊:European Journal of Ophthalmology [SAGE]
卷期号:: 11206721251392630-11206721251392630
标识
DOI:10.1177/11206721251392630
摘要

Purpose To report clinical (visual and refractive), spectacle independence, patient-reported outcomes following bilateral sequential implantation of a non-diffractive extended-vision intraocular lens (IOL): AcrySof IQ Vivity (DFT015 and DFTx15) in cataract surgery. This IOL provides continuous range of focus from distance to near, offering monofocal quality distance image and visual disturbances profile. Methods Retrospective unmasked nonrandomized case series. Patients who underwent phacoemulsification and bilateral sequential implantation of AcrySof IQ Vivity, targeting minimonovision (nondominant eye targeted for between −0.25D and −0.50D). Clinical post-operative outcome measures were assessed 1–2 months postoperatively - binocular uncorrected distance visual acuity (UDVA), binocular uncorrected intermediate visual acuity – 66 cm (UIVA), binocular uncorrected near visual acuity – 40 cm (UNVA), refraction, spherical equivalent (SE) and residual astigmatism (toric group). Spectacle independence and satisfaction systematic questionnaires (IOLSAT and Catquest-9SF) were performed. Visual disturbances were analyzed. Results 181 patients were enrolled. 78 eyes were implanted with the DFTx15 (toric version). Binocular mean UDVA was −0.01 logMAR (± 0.05), binocular mean UIVA was 0.09 logMAR (± 0.08), binocular mean UNVA was 0.16 logMAR (± 0.12) and mean SE was −0.27D (± 0.36D). Mean residual astigmatism (toric group) was 0.3D (± 0.42D). Patient-reported outcomes for satisfaction and spectacle independence were excellent. Visual disturbances were rarely reported. Conclusions Implanting this IOL using minimonovision strategy provides excellent binocular UDVA and UIVA, and good UNVA. It provides high patient satisfaction, spectacle independence (demonstrated excellent performance in systematic evaluations) and minimizes unwanted visual effects. Controlled designs and longer follow-ups are needed to confirm these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
时舒完成签到 ,获得积分10
2秒前
清脆冬日完成签到 ,获得积分10
2秒前
3秒前
3秒前
3秒前
风吹小白菜完成签到,获得积分10
3秒前
追寻荔枝发布了新的文献求助10
3秒前
Hhhhh完成签到 ,获得积分10
4秒前
nikehy完成签到,获得积分10
5秒前
梦漓完成签到 ,获得积分10
6秒前
宋祥瑞发布了新的文献求助10
6秒前
芋圆发布了新的文献求助10
6秒前
6秒前
俊杰发布了新的文献求助10
7秒前
8秒前
Dante完成签到,获得积分10
9秒前
刘桔发布了新的文献求助10
9秒前
爆米花应助追寻荔枝采纳,获得10
10秒前
张凯茜发布了新的文献求助10
10秒前
英俊的铭应助俊杰采纳,获得10
11秒前
paulmichael完成签到,获得积分10
12秒前
认真飞瑶完成签到 ,获得积分10
12秒前
BowieHuang应助科研通管家采纳,获得10
12秒前
在水一方应助科研通管家采纳,获得10
12秒前
超级幼旋应助科研通管家采纳,获得10
12秒前
脑洞疼应助科研通管家采纳,获得10
12秒前
科研通AI6应助科研通管家采纳,获得10
12秒前
科研通AI6应助科研通管家采纳,获得10
13秒前
传奇3应助科研通管家采纳,获得10
13秒前
BowieHuang应助科研通管家采纳,获得10
13秒前
深情安青应助科研通管家采纳,获得10
13秒前
13秒前
13秒前
13秒前
13秒前
paulmichael发布了新的文献求助10
14秒前
深情安青应助断章采纳,获得30
14秒前
米糊发布了新的文献求助20
14秒前
小二郎应助Dante采纳,获得20
14秒前
文静的夜梅完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Agriculture and Food Systems Third Edition 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
人脑智能与人工智能 1000
King Tyrant 720
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5600669
求助须知:如何正确求助?哪些是违规求助? 4686274
关于积分的说明 14842599
捐赠科研通 4677373
什么是DOI,文献DOI怎么找? 2538898
邀请新用户注册赠送积分活动 1505853
关于科研通互助平台的介绍 1471229